Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Genge

Showing results (41-50 of 111) with videos related to

Pageof 12
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 28, 2025
Variability across versions of the self-administered ALSFRS-R: a review and call for harmonizationMatti D Allen, Ruben P A Van Eijk, Liam Knox, et al.
Plos One|June 16, 2022
Functional alterations in large-scale resting-state networks of amyotrophic lateral sclerosis: A multi-site study across Canada and the United StatesKomal Bharti, Simon J Graham, Michael Benatar, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 24, 2018
Respiratory measures in amyotrophic lateral sclerosisNoah Lechtzin, Merit E Cudkowicz, Mamede de Carvalho, et al.
Brain Imaging and Behavior|November 6, 2020
Neuroanatomical associations of the Edinburgh cognitive and Behavioural ALS screen (ECAS)Sneha Chenji, Abdullah Ishaque, Dennell Mah, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|February 16, 2022
Validating Automatic Diadochokinesis Analysis Methods Across Dysarthria Severity and Syllable Task in Amyotrophic Lateral SclerosisChelsea Tanchip, Diego L Guarin, Scotia McKinlay, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 9, 2025
Utility of patient subgrouping in ALS clinical trials: a World Federation of Neurology white paperJeffrey Rosenfeld, Sharon Abrahams, Caroline McHutchinson, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 9, 2016
Pompe Disease: Diagnosis and Management. Evidence-Based Guidelines from a Canadian Expert PanelMark Tarnopolsky, Hans Katzberg, Basil J Petrof, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 7, 2020
Reliability and validity of speech & pause measures during passage reading in ALSCarolina Barnett, Jordan R Green, Reeman Marzouqah, et al.
AJNR. American Journal of Neuroradiology|September 18, 2025
Progressive and short-interval changes observed in the corticospinal tract and corpus callosum of ALS patients: A texture analysis studyPedram Parnianpour, Matthew Harrison, Michael Benatar, et al.
Scientific Reports|September 20, 2022
Rate of speech decline in individuals with amyotrophic lateral sclerosisMarziye Eshghi, Yana Yunusova, Kathryn P Connaghan, et al.
Pageof 12

Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 28, 2025
Variability across versions of the self-administered ALSFRS-R: a review and call for harmonizationMatti D Allen, Ruben P A Van Eijk, Liam Knox, et al.
Plos One|June 16, 2022
Functional alterations in large-scale resting-state networks of amyotrophic lateral sclerosis: A multi-site study across Canada and the United StatesKomal Bharti, Simon J Graham, Michael Benatar, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 24, 2018
Respiratory measures in amyotrophic lateral sclerosisNoah Lechtzin, Merit E Cudkowicz, Mamede de Carvalho, et al.
Brain Imaging and Behavior|November 6, 2020
Neuroanatomical associations of the Edinburgh cognitive and Behavioural ALS screen (ECAS)Sneha Chenji, Abdullah Ishaque, Dennell Mah, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|February 16, 2022
Validating Automatic Diadochokinesis Analysis Methods Across Dysarthria Severity and Syllable Task in Amyotrophic Lateral SclerosisChelsea Tanchip, Diego L Guarin, Scotia McKinlay, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 9, 2025
Utility of patient subgrouping in ALS clinical trials: a World Federation of Neurology white paperJeffrey Rosenfeld, Sharon Abrahams, Caroline McHutchinson, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 9, 2016
Pompe Disease: Diagnosis and Management. Evidence-Based Guidelines from a Canadian Expert PanelMark Tarnopolsky, Hans Katzberg, Basil J Petrof, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 7, 2020
Reliability and validity of speech & pause measures during passage reading in ALSCarolina Barnett, Jordan R Green, Reeman Marzouqah, et al.
AJNR. American Journal of Neuroradiology|September 18, 2025
Progressive and short-interval changes observed in the corticospinal tract and corpus callosum of ALS patients: A texture analysis studyPedram Parnianpour, Matthew Harrison, Michael Benatar, et al.
Scientific Reports|September 20, 2022
Rate of speech decline in individuals with amyotrophic lateral sclerosisMarziye Eshghi, Yana Yunusova, Kathryn P Connaghan, et al.
Pageof 12